BioSpace News Archive

STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced financial results for the second quarter ended June 30, 2022.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced it has commenced an underwritten public offering of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock.

Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today reported financial results for the second quarter ended June 30, 2022 and provided a corporate update.

Cerevel Therapeutics Holdings, Inc., a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that it has commenced an underwritten public offering of $250.0 million of shares of its common stock.

Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results for the second quarter ended June 30, 2022, and provided a business update.

Alpha Teknova, Inc., a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, announced financial results for the second quarter ended June 30, 2022.

A new study in the August 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network suggests a new way for hematologic oncologists to protect older patients from the risks of medication interactions.

According to the report, the global PCR & real-time PCR molecular market was valued over US$ 4.1 Bn in 2021.

Panacell Biotech Co., Ltd. said that NK cells, exosomes, and brown adipose-derived stem cells are effective to treat patients with long COVID conditions, or post COVID-19 conditions, as well as those with terminal illness.

According to Nova one advisor’s latest research report on the global Artificial Intelligence in Healthcare market size was estimated at USD 10.9 billion in 2021 and is expected to surpass around USD 209.1 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 39.4% during the forecast period 2022 to 2030.